RX.V BIOYF BioSyent Releases Results for Third Quarter and First Nine Months of 2015. http://finance.yahoo.com/news/biosyent-releases-results-third-quarter-130000267.html Third quarter (Q3) 2015 Revenues of $4,646,236 increased by 28% versus Q3 2014. Q3 2015 Net Income After Tax of $1,188,536 increased by 19% versus Q3 2014. ROE is 40% and they're launching a new product in the 4th quarter.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.